Biography of Lori Friedman
Last update: February 12, 2024Career
Lori was Senior Director, Translational Oncology at Sr. Director, Translational Oncology, and Director, Signal Transduction Research at Exelixis. Lori Friedman joined Oric Pharmaceuticals in 2023.
Lori Friedman is currently- Chief Scientific Officer at Oric Pharmaceuticals - View - Oric Pharmaceuticals org chart
- Director at NextRNA Therapeutics - View - NextRNA Therapeutics org chart
Create your alert
to follow the career of Lori Friedman.
Education
Lori Friedman has a PhD in Molecular and Cell Biology from University of California, Berkeley and a Post-Doctoral in Breast Cancer Genetics from University of Cambridge.
They have also studied at University of California, Berkeley :
Find more alumni from University of California, Berkeley
They have also studied at University of Cambridge :
Find more alumni from University of Cambridge
More about Lori Friedman
Selected links
Do you need to know more about Lori Friedman? More results.
Participate
Social media
- Lori Friedman on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Lori Friedman
The colleagues of Lori Friedman
Company Colleagues
- At Oric Pharmaceuticals, Lori Friedman has 12 colleagues including Jacob Chacko (CEO & Director), Mardi Dier (Director)…
- At NextRNA Therapeutics, Lori Friedman has 16 colleagues including Dominique Verhelle (CEO), William McKee (Director)…
Industry Colleagues
- In the Pharmaceuticals industry, Lori Friedman has 19,336 colleagues in 1,864 companies located in 69 countries. 8,427 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Lori Friedman.
Get in Touch
and ask for Lori Friedman.
